Warren Lammert

Chief Executive Officer at

Granite Point Capital Management LP

Health Technology

Finance

Commercial Services

Profile

Warren Burnet Lammert is the founder of Granite Point Capital Management LP, serving as Chief Investment Officer since 2004, and Tevard Biosciences, Inc., serving as Chairman since 2017.
Current jobs include Director at Receptor Life Sciences, Inc. and Director at Engage Therapeutics, Inc. Former jobs include Chairman at Cerebral Therapeutics, Inc., Director at Biscayne Pharmaceuticals, Inc., Director at Epilepsy Foundation, Director at Biscayne Neurotherapeutics, Inc., Research Associate at Fred Alger Management LLC, and Portfolio Manager at Janus Henderson Investors US LLC from 1987 to 2003.
Education includes an undergraduate degree from Yale University, conferred in 1984, and a graduate degree from London School of Economics & Political Science, conferred in 1989.

Warren Lammert active positions

Companies	Position	Start
Granite Point Capital Management LP Granite Point Capital Management LP Investment ManagersFinance Great Point Capital invests globally and focuses on small- to mid-cap US equities.	Chief Executive Officer	12/01/2004
Engage Therapeutics, Inc. Engage Therapeutics, Inc. BiotechnologyHealth Technology Develops rescue therapy for uncontrolled epileptic seizures	Director/Board Member	-
Tevard Biosciences, Inc. Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases	Founder	30/08/2017
Receptor Life Sciences, Inc. Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutic products	Director/Board Member	-

All active positions of Warren Lammert

Former positions of Warren Lammert

Companies	Position	End
Janus Henderson Investors US LLC Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis.	Portfolio Manager-Equities	30/12/2003
Fred Alger Management LLC Fred Alger Management LLC Investment ManagersFinance FAM is a growth manager that uses proprietary, bottom-up, fundamental research to identify companies that are undergoing positive dynamic change. The firm invests in companies experiencing high unit volume growth and/or companies undergoing a positive life cycle change.	Analyst-Equity	30/12/1986
Cerebral Therapeutics, Inc. Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases	Chairman	-
Biscayne Pharmaceuticals, Inc. Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products	Director/Board Member	-
Biscayne Neurotherapeutics, Inc. Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders	Director/Board Member	-

See the detail of Warren Lammert's experience

Training of Warren Lammert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Warren Lammert's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Fred Alger Management LLC Fred Alger Management LLC Investment ManagersFinance FAM is a growth manager that uses proprietary, bottom-up, fundamental research to identify companies that are undergoing positive dynamic change. The firm invests in companies experiencing high unit volume growth and/or companies undergoing a positive life cycle change.	Finance
Janus Henderson Investors US LLC Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis.	Finance
Biscayne Pharmaceuticals, Inc. Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products	Health Technology
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
London School of Economics & Political Science London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Epilepsy Foundation Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Provides welfare services to people with epilepsy	Commercial Services
Granite Point Capital Management LP Granite Point Capital Management LP Investment ManagersFinance Great Point Capital invests globally and focuses on small- to mid-cap US equities.	Finance
Biscayne Neurotherapeutics, Inc. Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders	Health Technology
Receptor Life Sciences, Inc. Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutic products	Health Technology
Engage Therapeutics, Inc. Engage Therapeutics, Inc. BiotechnologyHealth Technology Develops rescue therapy for uncontrolled epileptic seizures	Health Technology
Cerebral Therapeutics, Inc. Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases	Commercial Services
Tevard Biosciences, Inc. Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases	Commercial Services